ARS Pharmaceuticals (SPRY) Shares Issued (2021 - 2025)
Historic Shares Issued for ARS Pharmaceuticals (SPRY) over the last 5 years, with Q3 2025 value amounting to $479000.0.
- ARS Pharmaceuticals' Shares Issued fell 2955.88% to $479000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 6526.76%. This contributed to the annual value of $3.0 million for FY2024, which is 5628.35% down from last year.
- ARS Pharmaceuticals' Shares Issued amounted to $479000.0 in Q3 2025, which was down 2955.88% from $2.7 million recorded in Q2 2025.
- Over the past 5 years, ARS Pharmaceuticals' Shares Issued peaked at $2.9 million during Q2 2023, and registered a low of -$1.0 million during Q4 2021.
- For the 5-year period, ARS Pharmaceuticals' Shares Issued averaged around $856176.5, with its median value being $680000.0 (2024).
- In the last 5 years, ARS Pharmaceuticals' Shares Issued skyrocketed by 89442.51% in 2023 and then crashed by 8090.4% in 2024.
- ARS Pharmaceuticals' Shares Issued (Quarter) stood at -$1.0 million in 2021, then surged by 127.85% to $283000.0 in 2022, then surged by 537.81% to $1.8 million in 2023, then dropped by 15.07% to $1.5 million in 2024, then crashed by 68.75% to $479000.0 in 2025.
- Its Shares Issued stands at $479000.0 for Q3 2025, versus $2.7 million for Q2 2025 and $725000.0 for Q1 2025.